Chamber and committees

To date, we have been laying the foundations to deliver on Scotland’s first National Transitions to Adulthood Strategy to support disabled young people as they make the transition to young adult life, through research and engagement.

The scope, vision, aims and national priorities for the strategy will now be developed through external stakeholder engagement and wider consultation. Staffing costs for this work will be met from our operating costs budget for 2023-24.

The costs associated with the implementation of the Strategy will be determined by the actions that are developed and ultimately included, once agreed.

In Scotland, the Scottish Medicines Consortium (SMC) appraises the clinical and cost-effectiveness of newly-licensed medicines. Following receipt of a submission from the manufacturer, the SMC carries out an appraisal of the medicine and then determines whether it should be accepted for routine use within the NHS in Scotland. The SMC appraisal is undertaken independently of Scottish Ministers and is based on the clinical and cost-effectiveness of the medicine at a population level. Following the appraisal process, the SMC publishes advice for NHS Scotland Health Boards to consider. The decision to prescribe a medicine for a patient, and which medicine to prescribe, is entirely for the clinician in charge of a patient’s care, having taken into account the patient’s clinical condition and any relevant clinical guidance.

I refer the member to the answer to question S6W-15269 on 8 March 2023. All answers to written parliamentary questions are available on the Parliament's website, the search facility for which can be found at Questions and answers | Scottish Parliament Website .

The Scottish Government is committed to ensuring that people living in Scotland with long term conditions such as rheumatoid arthritis are able to access the best possible care and support.

The Scottish Government is working to ensure an overarching approach for advanced therapy medicinal products (ATMPs) is in place in order to facilitate a ‘once for Scotland’ approach, where possible. We recognise that there are wide-ranging implications and challenges for the managed introduction of these personalised medicines, and are committed to adopting a co-ordinated approach where practical. We are working across Government to develop our understanding of the future direction for this area of medicines policy, including associated genomic testing and service planning implications for the NHS.

The global pandemic was the biggest shock our NHS has faced in its 74 year existence. Our NHS Recovery Plan published on 25 August 2021 invests £1 billion of targeted funding over five years to increase NHS capacity, deliver reform, and ensure everyone has the treatment they need at the right time, in the right place, and as quickly as possible.

The Scottish Government expects health care professionals to deliver high quality person-centred care in line with best practice guidance. The NICE (National Institute for Health and Care Excellence) guideline on management of rheumatoid arthritis in adults (NG100) is available on its website: www.nice.org.uk. The Scottish Intercollegiate Guidelines Network (SIGN) guideline on management of psoriatic arthritis in adults (SIGN 121) is available on its website: www.sign.ac.uk.

The information requested is not held centrally and is a matter for NHS Boards locally.

Social Security Scotland does not routinely produce information on households claiming social security benefits.

Information on the characteristics of applicants, including gender, is published as part of Official Statistics publications on Social Security Scotland client diversity and equalities analysis.

These statistics were most recently published in September 2021 and are available at: https://www.socialsecurity.gov.scot/reporting/publications/social-security-scotland-client-diversity-and-equalities-analysis-to-may-2021 .

There is currently work being undertaken to produce an update to this publication, which will be published by the end of summer 2023. This will cover the period from June 2021 to October 2022.

Social Security Scotland does not routinely produce information on couples claiming social security benefits.

Information on the characteristics of applicants, including gender, is published as part of Official Statistics publications on Social Security Scotland client diversity and equalities analysis.

These statistics were most recently published in September 2021 and are available at: https://www.socialsecurity.gov.scot/reporting/publications/social-security-scotland-client-diversity-and-equalities-analysis-to-may-2021.

There is currently work being undertaken to produce an update to this publication, which will be published by the end of summer 2023. This will cover the period from June 2021 to October 2022.

The consultation on the eligibility criteria for the mobility component of Adult Disability Payment opened on 31 January 2023 and will close on 25 April 2023.

The consultation can be accessed via https://consult.gov.scot/social-security/adult-disability-payment-review .

People can also engage with the consultation through a series of consultation events during February and March 2023.

Registration for consultation events can be accessed via https://www.tickettailor.com/events/adpreviewevents .